[Use of cortisone in the symptomatic treatment of malignant bronchopulmonary tumors]

86% of 1703 subjects with primary malignant bronchopulmonary tumours treated over a period of 5 years responded solely to symptomatic management. Attention is drawn to the poor results offered by polychemotherapy and to satisfactory treatment of 82 patients with 6-methylprednisolone acetate. This drug was chosen on account of its ease of administration and fewer side-effects by comparison with cortisones given per os.